After signing up, you'll start to receive regular news updates from us.
BioMachines Announces New Proteomics Services Division
Complete the form below to unlock access to ALL audio articles.
BioMachines Inc. has announced a new services division - Applied Proteomics Services. The new division of BioMachines is the result of an exclusive agreement with the University of Massachusetts Medical School’s Proteomic Fractionation Group (PFG).
BioMachines will leverage the experience of Sunny Tam, PhD and Douglas Hinerfeld, PhD to manage and operate the Applied Proteomics Services group.
The group provides diverse proteomic sample preparation, fractionation and mass spectrometry services for analysis.
Applied Proteomics Services will utilizes its fully integrated technology platform to provide real advantages in data quality, throughput and the ability to review, interpret and troubleshoot experimental outcomes.
"This exclusive partnership combines the deep knowledge and expertise of the PFG team with proven sample preparation automation equipment, to offer our customers the best combined set of resources on the market," said Tom Larrichio, BioMachines’ Chief Executive Officer.
"Proteinbased biopharmaceuticals are enjoying great commercial success. Specifically, monoclonal antibodies are a very exciting area, where sales are projected to grow from a $15 billion market in 2005 to a $27 billion market in 2010."
"This is in addition to protein analysis that is required for small-molecule therapies."
"We are focused on this growing market by providing expertise in protein analysis through a fee-for-services model."
"We are delighted about this collaborative relationship with BioMachines so that we can reach out and serve more clients in this exciting technology area," said Sunny Tam, PhD and Douglas Hinerfeld, PhD.
"By working closely with the cutting edge equipment from BioMachines, our technology platform will be expanded and more biopharmaceutical applications utilizing our proteomic expertise will be created."
